SME Times is powered by   
Search News
Just in:   • RBI leaves repo rate unchanged, sticks to neutral policy stance  • EU, US trade deals to support exports over medium-term: RBI Governor  • Is it time for SMEs to look beyond Google?  • Ensuring energy security of 1.4 billion Indians remains govt's supreme priority: MEA  • Foreign firms to meet 4 essential conditions to qualify for tax holiday benefits 
Last updated: 13 Mar, 2023  

Tablet.9.Thmb.jpg Centre mulling taking action against e-pharmacies over data misuse

Tablet.9.jpg
   Top Stories
» EU, US trade deals to support exports over medium-term: RBI Governor
» Ensuring energy security of 1.4 billion Indians remains govt's supreme priority: MEA
» After Budget and India-US trade deal, all eyes on RBI’s repo rate decision
» US tariffs on Indian goods among lowest after trade deal
» Indian rupee trades over 1 pc higher after US trade deal
IANS | 14 Mar, 2023
The Centre is planning to regulate the e-pharmacy industry over misuse of data, sources said.

According to a source, the Health Ministry is working on a policy to regulate the e-pharmacy industry market in the country, and a Group of Ministers (GoM) are in favour of the closure of e-pharmacies. "They did not propose the idea in the present shape. The government can take action against them," the source said.

"Health Ministry has taken note of malpractices reported in the sector which lead to concerns over data privacy, sales of medicines without prescription, and predatory pricing," the source added.

The action follows after the Drugs Controller General of India (DCGI) last month issued a show-cause notice on online pharmacies asking them why action should not be taken against them for selling and distributing drugs without licence.

The notice was issued to online pharmacies including Tata 1mg, Amazon, and Flipkart, for selling and distributing drugs in contravention of provisions of the Drugs and Cosmetics Act, 1940.

"This office has received various representations from time to time raising concerns regarding sale of drugs through online, internet or other electronic platforms including various mobile applications, in contravention to the provisions of the Drugs and Cosmetics Act, 1940 & Rules there under. Such sale includes drugs specified in Schedule H, HI and X which are only allowed to be sold by retail under a valid prescription of a registered medical practitioner and supplied under the supervision of a registered pharmacist," the DCGI had said in the notice.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹91.2
₹89.5
UK Pound
₹123.35
₹119.35
Euro
₹107
₹103.35
Japanese Yen ₹57.9 ₹56.1
As on 22 Jan, 2026
  Daily Poll
What is your primary "Make or Break" expectation from the Finance Minister this year?
 The Tax Relief
 The Working Capital Fix
 The Compliance Holiday
 The Payment Shield
 The Tech Subsidy
 All
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter